• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴基斯坦三级医疗环境下充血性心力衰竭的核心措施

Core Measures for Congestive Heart Failure in a Tertiary Care Setting in Pakistan.

作者信息

Zafar Rizwan, Haris Muhammad, Assad Salman, Shabbir Muhammad Usman, Ghazanfar Haider, Malik Sarah A, Khalid Tehreem, Abbas Ali H, Saleem Asad A

机构信息

Department of Cardiology, Shifa College of Medicine, Islamabad, Pakistan.

Department of Neurology & Neurosurgery, Shifa Tameer-e-Millat University, Islamabad, Pakistan.

出版信息

Cureus. 2016 Aug 8;8(8):e728. doi: 10.7759/cureus.728.

DOI:10.7759/cureus.728
PMID:27630801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5016042/
Abstract

PURPOSE

Heart failure presents a huge burden for individual patients and the healthcare system as a whole. This study aims to assess the adherence to these core measures as identified by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO)/ American Heart Association (AHA) by physicians of Pakistan.

MATERIALS AND METHODOLOGY

We conducted a cross-sectional study in Shifa International Hospital, Islamabad, Pakistan from the period of April 2013 to April 2016. Patients with a primary diagnosis of heart failure were drawn from a coding section of hospital's record department. Data was evaluated to assess how strictly doctors were following core measures identified by JCAHO/AHA for the given diagnosis. Inclusion criteria for this study were patients ≥ 17 years of age and patients with a primary diagnosis of heart failure according to New York Heart Association (NYHA) classification. Patients with congenital anomalies and structural heart wall problems, like sarcoidosis, hemochromatosis, and amyloidosis, were excluded from the study.

RESULTS

Mean ejection fraction (EF) was found to be 27.23 ± 11.72 percent. Symptoms assessment of heart failure was done in 16/421 (3.8%) patients according to NYHA classification and in 405/421 (96.2%) patients according to outpatient-based heart failure assessment based on physician's experience other than NYHA classification. Left ventricle ejection fraction (LVEF) was assessed in 411/421 (97%) patients. Out of these, 336/411 (81.7%) patients had EF < 40%. Mean EF was found to be significantly higher in females as compared to males (p < 0.001). Three hundred and thirty-six out of 411 (81.7%) patients with EF < 40% needed angiotensin converting enzyme inhibitors (ACEi) and beta-blocker (BB) prescriptions. ACEi were prescribed only to 230/336 (68.7%) patients and 248/336 (73.8%) patients were given BB with documented contraindication to ACEi and BB in 7.36% and 17% patients, respectively. There was no significant association between gender and mean duration of hospitalization (p = 0.411). No significant association was found between EF ≤ 40% and mean duration of hospitalization (p = 0.426).

CONCLUSION

We found that symptom assessment of congestive heart failure (CHF) patients, according to NYHA guidelines, are strikingly low. Also, a significant percentage of patients who need ACEi and BB are not prescribed the required medications despite echocardiography showing low left ventricular function.

摘要

目的

心力衰竭给个体患者及整个医疗保健系统带来了巨大负担。本研究旨在评估巴基斯坦医生对医疗机构评审联合委员会(JCAHO)/美国心脏协会(AHA)所确定的这些核心措施的依从性。

材料与方法

我们于2013年4月至2016年4月在巴基斯坦伊斯兰堡的希法国际医院进行了一项横断面研究。原发性心力衰竭患者从医院记录部门的编码科室选取。对数据进行评估,以评估医生对JCAHO/AHA针对给定诊断所确定的核心措施的遵循程度。本研究的纳入标准为年龄≥17岁且根据纽约心脏协会(NYHA)分类为原发性心力衰竭的患者。患有先天性异常和结构性心脏壁问题(如结节病、血色素沉着症和淀粉样变性)的患者被排除在研究之外。

结果

平均射血分数(EF)为27.23±11.72%。根据NYHA分类,16/421(3.8%)的患者进行了心力衰竭症状评估,而根据基于医生经验而非NYHA分类的门诊心力衰竭评估,405/421(96.2%)的患者进行了评估。411/421(97%)的患者进行了左心室射血分数(LVEF)评估。其中,336/411(81.7%)的患者EF<40%。发现女性的平均EF显著高于男性(p<0.001)。411例EF<40%的患者中有336例(81.7%)需要血管紧张素转换酶抑制剂(ACEi)和β受体阻滞剂(BB)处方。ACEi仅开给230/336(68.7%)的患者,248/336(73.8%)的患者接受了BB治疗,分别有7.36%和17%的患者有ACEi和BB的记录在案的禁忌证。性别与平均住院时间之间无显著关联(p = 0.411)。EF≤40%与平均住院时间之间未发现显著关联(p = 0.426)。

结论

我们发现,根据NYHA指南,充血性心力衰竭(CHF)患者的症状评估极低。此外,尽管超声心动图显示左心室功能低下,但很大一部分需要ACEi和BB的患者并未被开具所需药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84f7/5016042/4762bb889178/cureus-0008-000000000728-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84f7/5016042/4762bb889178/cureus-0008-000000000728-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84f7/5016042/4762bb889178/cureus-0008-000000000728-i01.jpg

相似文献

1
Core Measures for Congestive Heart Failure in a Tertiary Care Setting in Pakistan.巴基斯坦三级医疗环境下充血性心力衰竭的核心措施
Cureus. 2016 Aug 8;8(8):e728. doi: 10.7759/cureus.728.
2
Combination pharmacotherapies for cardiac reverse remodeling in heart failure patients with reduced ejection fraction: A systematic review and network meta-analysis of randomized clinical trials.联合药物治疗心力衰竭射血分数降低患者的心脏逆重构:随机临床试验的系统评价和网络荟萃分析。
Pharmacol Res. 2021 Jul;169:105573. doi: 10.1016/j.phrs.2021.105573. Epub 2021 Mar 22.
3
[Comparative study on characteristics of congestive heart failure patients with preserved versus abnormal left ventricular systolic function and evaluation effects of therapy].左心室收缩功能正常与异常的充血性心力衰竭患者特征的比较研究及治疗评估效果
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006 Apr;18(4):210-5.
4
Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study.缬沙坦对心力衰竭患者左心室结构和功能有益:缬沙坦心力衰竭试验(Val-HeFT)超声心动图研究。
J Am Coll Cardiol. 2002 Sep 4;40(5):970-5. doi: 10.1016/s0735-1097(02)02063-6.
5
Long-Term Mortality and Morbidity Related to Congestive Heart Failure with Reduced Ejection Fraction (CHFrEF) in Palestinian Patients Maintained on Submaximal Sacubitril/Valsartan Doses: A Pilot Study.巴勒斯坦射血分数降低的心力衰竭(CHFrEF)患者在亚最大剂量沙库巴曲缬沙坦治疗下的长期死亡率和相关发病率:一项初步研究。
J Renin Angiotensin Aldosterone Syst. 2021 Dec 28;2021:1829873. doi: 10.1155/2021/1829873. eCollection 2021.
6
Safety and Efficacy of Traditional Heart Failure Therapies in Patients With Cardiac Amyloidosis and Heart Failure.在患有心脏淀粉样变性和心力衰竭的患者中,传统心力衰竭治疗的安全性和疗效。
Am J Cardiol. 2023 Oct 1;204:360-365. doi: 10.1016/j.amjcard.2023.07.140. Epub 2023 Aug 11.
7
A Single-Center, Open-Label, Randomized, Parallel-Group Study Assessing the Differences Between an Angiotensin II Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor in Hypertensive Patients with Congestive Heart Failure: The Research for Efficacy of Angiotensin II Receptor Antagonist in Hypertensive Patients with Congestive Heart Failure Study.一项单中心、开放标签、随机、平行组研究,评估血管紧张素II受体拮抗剂与血管紧张素转换酶抑制剂在充血性心力衰竭高血压患者中的差异:血管紧张素II受体拮抗剂在充血性心力衰竭高血压患者中的疗效研究
Curr Ther Res Clin Exp. 2003 Feb;64(2):81-94. doi: 10.1016/S0011-393X(03)00020-1.
8
Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database Analysis.新诊断心力衰竭患者的治疗起始模式、调整和药物依从性:一项回顾性理赔数据库分析。
J Manag Care Spec Pharm. 2016 May;22(5):561-71. doi: 10.18553/jmcp.2016.22.5.561.
9
Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.射血分数对沙库巴曲缬沙坦(LCZ696)治疗射血分数降低的心力衰竭的疗效及预后的影响:ARNI与ACEI对心力衰竭全球死亡率和发病率影响的前瞻性比较(PARADIGM-HF)试验
Circ Heart Fail. 2016 Mar;9(3):e002744. doi: 10.1161/CIRCHEARTFAILURE.115.002744.
10
Pharmacotherapy in patients with heart failure with reduced ejection fraction: A systematic review and meta-analysis.射血分数降低的心力衰竭患者的药物治疗:一项系统评价和荟萃分析。
Chin Med J (Engl). 2025 Apr 20;138(8):925-933. doi: 10.1097/CM9.0000000000003118. Epub 2024 May 28.

本文引用的文献

1
Prevalence of Heart Failure and Adherence to Process Indicators: Which Socio-Demographic Determinants are Involved?心力衰竭的患病率及对流程指标的依从性:涉及哪些社会人口学决定因素?
Int J Environ Res Public Health. 2016 Feb 19;13(2):238. doi: 10.3390/ijerph13020238.
2
Prevalence of heart failure in Australia: a systematic review.澳大利亚心力衰竭的患病率:一项系统综述。
BMC Cardiovasc Disord. 2016 Feb 6;16:32. doi: 10.1186/s12872-016-0208-4.
3
Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
静息心率及β受体阻滞剂的使用在射血分数降低的心力衰竭患者房颤和窦性心律中的预后意义:来自瑞典心力衰竭登记处的研究结果
Circ Heart Fail. 2015 Sep;8(5):871-9. doi: 10.1161/CIRCHEARTFAILURE.115.002285. Epub 2015 Aug 4.
4
Influence of drug adherence and medical care on heart failure outcome in the primary care setting in Austria.药物依从性和医疗护理对奥地利初级医疗环境中心力衰竭结局的影响。
Pharmacoepidemiol Drug Saf. 2015 Jul;24(7):722-30. doi: 10.1002/pds.3790. Epub 2015 May 18.
5
Epidemiology of heart failure.心力衰竭的流行病学。
Circ Res. 2013 Aug 30;113(6):646-59. doi: 10.1161/CIRCRESAHA.113.300268.
6
Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction.血管紧张素转换酶抑制剂在射血分数保留的心力衰竭中的结局。
Am J Med. 2013 May;126(5):401-10. doi: 10.1016/j.amjmed.2013.01.004. Epub 2013 Mar 16.
7
Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction.射血分数降低和射血分数保留的急性失代偿性心力衰竭住院患者的性别差异。
Am Heart J. 2012 Mar;163(3):430-7, 437.e1-3. doi: 10.1016/j.ahj.2011.12.013.
8
Adherence to the European Society of Cardiology (ESC) guidelines for chronic heart failure--a national survey of the cardiologists in Pakistan.遵守欧洲心脏病学会(ESC)慢性心力衰竭指南——巴基斯坦心脏病专家的全国调查。
BMC Cardiovasc Disord. 2011 Nov 17;11:68. doi: 10.1186/1471-2261-11-68.
9
The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.射血分数保留或降低的心力衰竭患者的生存情况:一项个体患者数据荟萃分析。
Eur Heart J. 2012 Jul;33(14):1750-7. doi: 10.1093/eurheartj/ehr254. Epub 2011 Aug 6.
10
Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF).门诊心内科实践中遵循指南推荐的心力衰竭辅助治疗的情况(来自 IMPROVE HF 的发现)。
Am J Cardiol. 2010 Jan 15;105(2):255-60. doi: 10.1016/j.amjcard.2009.08.681.